OPKO Health Price to Book Ratio 2010-2023 | OPK
Historical price to book ratio values for OPKO Health (OPK) over the last 10 years. The current price to book ratio for OPKO Health as of March 28, 2024 is 0.60.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
OPKO Health Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-03-28 | 1.20 | 0.67 | |
2023-12-31 | 1.51 | $1.80 | 0.84 |
2023-09-30 | 1.60 | $1.87 | 0.86 |
2023-06-30 | 2.17 | $1.99 | 1.09 |
2023-03-31 | 1.46 | $2.01 | 0.73 |
2022-12-31 | 1.25 | $2.02 | 0.62 |
2022-09-30 | 1.89 | $2.11 | 0.90 |
2022-06-30 | 2.53 | $2.23 | 1.14 |
2022-03-31 | 3.44 | $2.37 | 1.45 |
2021-12-31 | 4.81 | $2.47 | 1.95 |
2021-09-30 | 3.65 | $2.59 | 1.41 |
2021-06-30 | 4.05 | $2.56 | 1.58 |
2021-03-31 | 4.29 | $2.53 | 1.69 |
2020-12-31 | 3.95 | $2.49 | 1.58 |
2020-09-30 | 3.69 | $2.42 | 1.52 |
2020-06-30 | 3.41 | $2.37 | 1.44 |
2020-03-31 | 1.34 | $2.31 | 0.58 |
2019-12-31 | 1.47 | $2.41 | 0.61 |
2019-09-30 | 2.09 | $2.67 | 0.78 |
2019-06-30 | 2.44 | $2.78 | 0.88 |
2018-12-31 | 3.01 | $3.06 | 0.99 |
2018-09-30 | 3.46 | $3.20 | 1.08 |
2018-06-30 | 4.70 | $3.24 | 1.45 |
2018-03-31 | 3.17 | $3.26 | 0.97 |
2017-12-31 | 4.90 | $3.30 | 1.49 |
2019-03-31 | 2.61 | $2.86 | 0.91 |
2017-09-30 | 6.86 | $3.73 | 1.84 |
2017-06-30 | 6.58 | $3.77 | 1.75 |
2017-03-31 | 8.00 | $3.77 | 2.12 |
2016-12-31 | 9.30 | $3.75 | 2.48 |
2016-09-30 | 10.59 | $3.78 | 2.80 |
2016-06-30 | 9.34 | $3.68 | 2.54 |
2016-03-31 | 10.39 | $3.65 | 2.85 |
2015-12-31 | 10.05 | $3.63 | 2.77 |
2015-09-30 | 8.41 | $3.61 | 2.33 |
2015-06-30 | 16.08 | $1.78 | 9.01 |
2015-03-31 | 14.17 | $1.77 | 7.99 |
2014-12-31 | 9.99 | $1.93 | 5.17 |
2014-09-30 | 8.51 | $2.06 | 4.14 |
2014-06-30 | 8.84 | $2.14 | 4.12 |
2014-03-31 | 9.32 | $2.01 | 4.63 |
2013-12-31 | 8.44 | $2.12 | 3.99 |
2013-09-30 | 8.81 | $2.13 | 4.13 |
2013-06-30 | 7.10 | $0.93 | 7.65 |
2013-03-31 | 7.63 | $0.95 | 8.03 |
2012-12-31 | 4.81 | $0.59 | 8.15 |
2012-09-30 | 4.18 | $0.49 | 8.45 |
2012-06-30 | 4.60 | $0.51 | 8.97 |
2011-12-31 | 4.90 | $0.54 | 9.06 |
2011-09-30 | 4.33 | $0.36 | 12.07 |
2011-06-30 | 3.69 | $0.39 | 9.56 |
2011-03-31 | 3.73 | $0.43 | 8.60 |
2010-12-31 | 3.67 | $0.09 | 40.64 |
2012-03-31 | 4.73 | $0.53 | 9.01 |
2010-09-30 | 2.24 | $0.08 | 28.39 |
2010-06-30 | 2.26 | $0.20 | 11.52 |
2010-03-31 | 1.98 | $0.22 | 9.05 |
2009-12-31 | 1.83 | $0.12 | 14.70 |
2009-09-30 | 2.28 | $0.25 | 8.99 |
2009-03-31 | 0.98 | $-0.04 | -25.26 |
2009-06-30 | 1.77 | $0.15 | 11.49 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.746B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $220.921B | 26.90 |
Intuitive Surgical (ISRG) | United States | $141.815B | 88.52 |
Edwards Lifesciences (EW) | United States | $57.273B | 37.91 |
DexCom (DXCM) | United States | $53.772B | 92.37 |
IQVIA Holdings (IQV) | United States | $45.841B | 27.19 |
IDEXX Laboratories (IDXX) | United States | $44.833B | 53.58 |
Alcon (ALC) | Switzerland | $41.065B | 30.28 |
STERIS (STE) | Ireland | $22.285B | 26.38 |
Waters (WAT) | United States | $20.436B | 29.38 |
Hologic (HOLX) | United States | $18.156B | 20.04 |
SONOVA HOLDING (SONVY) | Switzerland | $17.399B | 0.00 |
ShockWave Medical (SWAV) | United States | $12.065B | 83.36 |
Sysmex ADR (SSMXY) | Japan | $11.407B | 35.78 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.361B | 14.03 |
Teleflex (TFX) | United States | $10.535B | 16.56 |
Penumbra (PEN) | United States | $8.762B | 108.32 |
Masimo (MASI) | United States | $7.645B | 42.87 |
Globus Medical (GMED) | United States | $7.183B | 22.77 |
Glaukos (GKOS) | United States | $4.585B | 0.00 |
Integer Holdings (ITGR) | United States | $3.844B | 24.64 |
LivaNova (LIVN) | United Kingdom | $3.015B | 19.88 |
Elekta AB (EKTAY) | Sweden | $2.904B | 19.92 |
Inari Medical (NARI) | United States | $2.747B | 474.00 |
Integra LifeSciences Holdings (IART) | United States | $2.738B | 11.23 |
PROCEPT BioRobotics (PRCT) | United States | $2.489B | 0.00 |
TransMedics (TMDX) | United States | $2.424B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.388B | 20.19 |
Tandem Diabetes Care (TNDM) | United States | $2.317B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.904B | 0.00 |
RxSight (RXST) | United States | $1.874B | 0.00 |
Veracyte (VCYT) | United States | $1.586B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.997B | 0.00 |
Paragon 28 (FNA) | United States | $0.987B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.919B | 17.01 |
Artivion (AORT) | United States | $0.891B | 103.00 |
Treace Medical Concepts (TMCI) | United States | $0.763B | 0.00 |
Silk Road Medical (SILK) | United States | $0.733B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.682B | 0.00 |
SiBone (SIBN) | United States | $0.650B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.579B | 19.64 |
IRadimed (IRMD) | United States | $0.549B | 31.89 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.535B | 0.00 |
Nevro (NVRO) | United States | $0.525B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.463B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.377B | 12.69 |
CVRx (CVRX) | United States | $0.376B | 0.00 |
NeuroPace (NPCE) | United States | $0.358B | 0.00 |
AxoGen (AXGN) | United States | $0.336B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.262B | 0.00 |
Sight Sciences (SGHT) | United States | $0.257B | 0.00 |
Accuray (ARAY) | United States | $0.241B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.229B | 0.00 |
908 Devices (MASS) | United States | $0.229B | 0.00 |
AngioDynamics (ANGO) | United States | $0.227B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.206B | 0.00 |
Semler Scientific (SMLR) | United States | $0.201B | 10.81 |
Inogen (INGN) | United States | $0.186B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.181B | 0.00 |
Neuronetics (STIM) | United States | $0.143B | 0.00 |
Delcath Systems (DCTH) | United States | $0.125B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.118B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
Envoy Medical (COCH) | United States | $0.076B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.073B | 0.00 |
Hyperfine (HYPR) | United States | $0.072B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.071B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.064B | 130.67 |
Vasomedical (VASO) | United States | $0.057B | 4.36 |
InspireMD (NSPR) | Israel | $0.054B | 0.00 |
Autonomix Medical (AMIX) | $0.052B | 0.00 | |
Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.048B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
LENSAR (LNSR) | United States | $0.043B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
DarioHealth (DRIO) | United States | $0.041B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.035B | 0.00 |
Spectral AI (MDAI) | United States | $0.034B | 0.00 |
Precision Optics (POCI) | United States | $0.034B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
PAVmed (PAVM) | United States | $0.025B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.022B | 0.00 |
PetVivo Holdings (PETV) | United States | $0.018B | 0.00 |
Check-Cap (CHEK) | Israel | $0.016B | 0.00 |
NexGel (NXGL) | United States | $0.015B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.015B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.009B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.007B | 0.00 |
Avinger (AVGR) | United States | $0.005B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |